logo
15:58 Feb 13

Morepen Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
38.55
-0.50 (-1.28%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Morepen Laboratories Ltd. Financials

Morepen Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
38.55
-0.50 (-1.28%)
15:58 Feb 13
Quality
image/svg+xml

48/100
Medium Financial Strength

Valuation
image/svg+xml

39/100
Mid Valuation

Technical

44/100
Technically Neutral

Strength

5

Weakness

0

Opportunity

0

Threats

0

10.20 %

ROE %

6.63 %

ROA %

1.81

EPS

21.10

BVPS

6.51 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
1546.83 1417.53 1690.43 1811.58 1786.83
Operating Expenses +
1410.16 1338 1531.81 1637.51 1643.43
Raw Material
1059.36 939.26 1060.31 1206.43 1157.06
Increase Decrease in Cost
-10.04 16.48 2.11 -47.12 -17.4
Other Manufacturing Expense
0 0 0 0 44.78
Employee Cost
164.25 154.68 181.47 208.91 230.99
Miscellaneous Expenses
721.05 543.28 641.92 683.79 228
Operating Profit
136.67 79.53 158.62 174.07 143.4
Other Income
10.31 6.13 13.97 18.36 17.47
Depreciation
27.64 27.93 33.47 28.98 47.16
Interest
-7.37 1.98 3.71 8.34 17.21
Profit before tax and exceptio..
126.7 55.76 135.42 155.11 96.5
Exceptional Items
0 0 0 0 25.83
PBT
126.7 55.76 135.42 155.11 70.67
Provision for Taxation
25.02 17.08 38.8 37.09 22.09
Net Profit
101.68 38.68 96.62 118.02 100.26
NET Profit after MI
101.68 38.68 96.16 118.02 99.45
EPS
2.26 0.77 1.88 2.2 1.8
Operating Profit Margin (%)
8.84 5.61 9.38 9.61 8.03
Net Profit Margin (%)
6.57 2.73 5.69 6.51 5.57

Morepen Laboratories Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: